Published in Cardiovasc Diabetol on February 18, 2015
Comparison of 2-year mortality according to obesity in stabilized patients with type 2 diabetes mellitus after acute myocardial infarction: results from the DIAMOND prospective cohort registry. Cardiovasc Diabetol (2015) 0.82
Does an Obesity Paradox Really Exist After Cardiovascular Intervention?: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies. Medicine (Baltimore) (2015) 0.79
Statin use and cardiovascular risk factors in diabetic patients developing a first myocardial infarction. Cardiovasc Diabetol (2016) 0.77
Associations between blood glucose level and outcomes of adult in-hospital cardiac arrest: a retrospective cohort study. Cardiovasc Diabetol (2016) 0.75
Moderate-intensity statin therapy seems ineffective in primary cardiovascular prevention in patients with type 2 diabetes complicated by nephropathy. A multicenter prospective 8 years follow up study. Cardiovasc Diabetol (2016) 0.75
Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006-2013). Cardiovasc Diabetol (2017) 0.75
Obesity alters molecular and functional cardiac responses to ischemia/reperfusion and glucagon-like peptide-1 receptor agonism. Basic Res Cardiol (2016) 0.75
Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser (2000) 70.59
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med (1998) 25.66
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA (2002) 8.81
Association of weight status with mortality in adults with incident diabetes. JAMA (2012) 7.49
Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol (2008) 5.28
Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med (2007) 4.64
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation (2006) 4.61
Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther (2009) 4.21
Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation (2009) 3.23
Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol (2011) 2.50
Inverse relation of body weight and weight change with mortality and morbidity in patients with type 2 diabetes and cardiovascular co-morbidity: an analysis of the PROactive study population. Int J Cardiol (2011) 1.89
The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J (2007) 1.85
Changes in body mass index following newly diagnosed type 2 diabetes and risk of cardiovascular mortality: a cohort study of 8486 primary-care patients. Diabetes Metab (2013) 1.55
Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study. Eur J Heart Fail (2010) 1.55
Body mass index and acute and long-term outcomes after acute myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial). Am J Cardiol (2014) 1.51
Impact of obesity on long-term prognosis following acute myocardial infarction. Int J Cardiol (2005) 1.47
Effect of obesity on short- and long-term mortality postcoronary revascularization: a meta-analysis. Obesity (Silver Spring) (2008) 1.46
Body mass index and mortality in acute myocardial infarction patients. Am J Med (2012) 1.42
Obesity paradox does exist. Diabetes Care (2013) 1.40
Impact of diabetes on long-term survival after acute myocardial infarction: comparability of risk with prior myocardial infarction. Diabetes Care (2001) 1.37
Body composition and mortality in a large cohort with preserved ejection fraction: untangling the obesity paradox. Mayo Clin Proc (2014) 1.26
Association between BMI measured within a year after diagnosis of type 2 diabetes and mortality. Diabetes Care (2012) 1.25
Obesity paradoxes. J Sports Sci (2011) 1.20
Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol (2007) 1.07
Obesity paradox in Korean patients undergoing primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. J Cardiol (2009) 1.03
New insights into the true nature of the obesity paradox and the lower cardiovascular risk. J Am Soc Hypertens (2013) 0.99
Impact of the body mass index on occurrence and outcome of acute ST-elevation myocardial infarction. Clin Res Cardiol (2007) 0.95
The obesity paradox in men versus women with systolic heart failure. Am J Cardiol (2012) 0.95
Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era. Am Heart J (2007) 0.94
Obesity and cardiovascular outcomes: a review. Eur Heart J Acute Cardiovasc Care (2014) 0.92
Influence of epicardial and visceral fat on left ventricular diastolic and systolic functions in patients after myocardial infarction. Am J Cardiol (2014) 0.92
Effect of morbid obesity on in-hospital mortality and coronary revascularization outcomes after acute myocardial infarction in the United States. Am J Cardiol (2013) 0.91
Association of body mass index and long-term outcomes in older patients with non-ST-segment-elevation myocardial infarction: results from the CRUSADE Registry. Circ Cardiovasc Qual Outcomes (2013) 0.89
Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era. Int J Cardiol (2005) 0.88
Body adiposity dictates different mechanisms of increased coronary reactivity related to improved in vivo cardiac function. Cardiovasc Diabetol (2014) 0.87
Should we prescribe statin and aspirin for every diabetic patient? Is it time for a polypill? Diabetes Care (2008) 0.84
Outcomes in diabetics undergoing revascularization: the long and the short of it. J Am Coll Cardiol (2002) 0.83
20-year trends in clinical characteristics, therapy and short-term prognosis in acute myocardial infarction according to presenting electrocardiogram: the MONICA/KORA AMI Registry (1985-2004). J Intern Med (2008) 0.82
Relation between body mass index, waist circumference, and cardiovascular outcomes in 19,579 diabetic patients with established vascular disease: the REACH Registry. Eur J Prev Cardiol (2011) 0.81
Long-term survival in patients with different combinations of evidence-based medications after incident acute myocardial infarction: results from the MONICA/KORA Myocardial Infarction Registry. Clin Res Cardiol (2014) 0.81
Association of metabolic syndrome and its individual components with outcomes among patients with high-risk non-ST-segment elevation acute coronary syndromes. Am Heart J (2014) 0.80
Higher body mass index at the time of acute myocardial infarction is associated with a favorable long-term prognosis (8-year follow-up). Heart Vessels (2011) 0.80
Impact of body mass index in the results after primary angioplasty in patients with ST segment elevation acute myocardial infarction. Acute Card Care (2011) 0.78